Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae.
Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D. Jansen WT, et al. J Antimicrob Chemother. 2006 Oct;58(4):873-7. doi: 10.1093/jac/dkl310. Epub 2006 Aug 4. J Antimicrob Chemother. 2006. PMID: 16891323
Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
Fluit AC, Schmitz FJ, Verhoef J, Milatovic D. Fluit AC, et al. Int J Antimicrob Agents. 2004 Jul;24(1):59-66. doi: 10.1016/j.ijantimicag.2003.12.014. Int J Antimicrob Agents. 2004. PMID: 15225863
In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.
Fluit AC, Schmitz FJ, Verhoef J, Milatovic D. Fluit AC, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):1007-11. doi: 10.1128/aac.48.3.1007-1011.2004. Antimicrob Agents Chemother. 2004. PMID: 14982796 Free PMC article.
Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil.
Rey LC, Wolf B, Moreira JL, Milatovic D, Verhoef J, Farhat CK. Rey LC, et al. Int J Antimicrob Agents. 2002 Aug;20(2):86-92. doi: 10.1016/s0924-8579(02)00128-0. Int J Antimicrob Agents. 2002. PMID: 12297356
In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status.
Schmitz FJ, Petridou J, Milatovic D, Verhoef J, Fluit AC, Schwarz S. Schmitz FJ, et al. J Antimicrob Chemother. 2002 Mar;49(3):580-2. doi: 10.1093/jac/49.3.580. J Antimicrob Chemother. 2002. PMID: 11864966 No abstract available.
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.
Milatovic D, Schmitz FJ, Verhoef J, Fluit AC. Milatovic D, et al. J Antimicrob Chemother. 2002 Aug;50(2):293-9. doi: 10.1093/jac/dkf098. J Antimicrob Chemother. 2002. PMID: 12161416 No abstract available.
Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA. Ekkelenkamp MB, et al. FEBS Lett. 2005 Mar 28;579(9):1917-22. doi: 10.1016/j.febslet.2005.01.083. FEBS Lett. 2005. PMID: 15792796
In vitro activity of AR-709 against Streptococcus pneumoniae.
Jansen WT, Verel A, Verhoef J, Milatovic D. Jansen WT, et al. Antimicrob Agents Chemother. 2008 Mar;52(3):1182-3. doi: 10.1128/AAC.01332-07. Epub 2008 Jan 7. Antimicrob Agents Chemother. 2008. PMID: 18180358 Free PMC article.
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
Schmitz FJ, Fluit AC, Milatovic D, Verhoef J, Heinz HP, Brisse S. Schmitz FJ, et al. J Antimicrob Chemother. 2000 Jul;46(1):109-13. doi: 10.1093/jac/46.1.109. J Antimicrob Chemother. 2000. PMID: 10882698
156 results
Jump to page
Feedback